Open Insider Trading Activity for Enanta Pharmaceuticals Inc Chief Product Strategy Officer Kieffer Tara Lynn
31-day price and insider activity (up to 2 years)
Daily candles with triangles for the buy and sale transactions shown below. Scroll left or zoom out to load earlier candles (up to 2 years).
▲ Insider buy
▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
| Ticker | Filing Date | Transaction Date | Company | Insider | Title | Transaction | Trade Count | Shares | Avg. Price | Total Value | Position Size Change | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10b5-1: Scheduled Form 4 Transaction ENTA | 2024-12-10 | 2024-12-06 | Enanta Pharmaceuticals Inc | Kieffer Tara Lynn | Chief Product Strategy Officer | Sell | 1 | 2,283 | $8.06 | $18,400.98 | 7.23% | View Filing |
| Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting ENTA | 2023-12-06 | 2023-12-05 | Enanta Pharmaceuticals Inc | Kieffer Tara Lynn | Sr. VP, New Prod. Strat. & Dev | Sell | 1 | 2,125 | $9.63 | $20,463.75 | 5.40% | View Filing |